Kyverna to take autoimmune CAR-T to FDA after success in stiff person syndrome trial

Kyverna Therapeutics' CAR-T therapy succeeded in a key study in stiff person syndrome, a rare autoimmune disorder that leads to painful muscle spasms and stiffness. The California biotech said Monday that ...